Home
>
National Drug Code (NDC)
>
Trileptal
Trileptal - 0078-0337-05 - (oxcarbazepine)
Drug Information of Trileptal
| Product NDC: | 0078-0337 |
| Proprietary Name: | Trileptal |
| Non Proprietary Name: | oxcarbazepine |
| Active Ingredient(s): | 300 mg/1 & nbsp; oxcarbazepine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Trileptal
| Product NDC: | 0078-0337 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021014 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20000130 |
Package Information of Trileptal
| Package NDC: | 0078-0337-05 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0078-0337-05) |
NDC Information of Trileptal
| NDC Code | 0078-0337-05 |
| Proprietary Name | Trileptal |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0078-0337-05) |
| Product NDC | 0078-0337 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | oxcarbazepine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20000130 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | OXCARBAZEPINE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
